Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.
Epistemonikos ID: d4374ad0dadb6528b3c40886f712d4b9ac7f4e1e
First added on: Feb 01, 2025